Skip to main content
Top
Published in:

17-07-2024 | Telemedicine | Original Research

Primary Care Telemedicine and Care Continuity: Implications for Timeliness and Short-term Follow-up Healthcare

Authors: Ilana Graetz, PhD, Jie Huang, PhD, Anjali Gopalan, MD, MS, Emilie Muelly, MD, PhD, Andrea Millman, MA, Mary E. Reed, DrPH

Published in: Journal of General Internal Medicine | Issue 13/2024

Login to get access

Abstract

Background

The effectiveness of telemedicine by a patient’s own primary care provider (PCP) versus another available PCP is understudied.

Objective

Examine the association between primary care visit modality with timeliness and follow-up in-person healthcare, including variation by visits with the patient’s own PCP versus another PCP.

Design and Participants

Cohort study including primary care visits in a large, integrated delivery system in 2022.

Measures

Outcomes included timeliness (visit completed within 7 days of scheduling) and in-person follow-up (PCP visits, emergency department (ED) visits, hospitalizations) within 7 days of the index PCP visit. Logistic regression measured the association between visit modality (in-person, video, and audio-only telemedicine) with the patient’s own PCP or another PCP and outcomes, adjusting for characteristics.

Key Results

Among 4,817,317 primary care visits, 59% were in-person, 27% audio-only, and 14% video telemedicine. Most (71.3%) were with the patient’s own PCP. Telemedicine visits were timelier, with modality having a larger association for visits with patient’s own PCP versus another PCP (P < 0.001). For visits with patient’s own PCPs, return office visit rates were 1.2% for in-person, 5.3% for video, and 6.1% for audio-only. For another PCP, rates were 2.2% for in-person, 7.3% for video, and 8.1% for audio. Follow-up ED visits ranged from 1.4% (in-person) to 1.6% (audio-only) with own PCP, compared to 1.9% (in-person) to 2.3% (audio-only) with another PCP. Differences in return office and ED visits between in-person and telemedicine were larger for visits with another PCP compared to their own PCP (P < 0.001). Follow-up hospitalizations were rare, ranging from 0.19% (in-person with own PCP) to 0.32% (video with another PCP).

Conclusion

Differences in return office and ED visits between in-person and telemedicine were larger when patients saw a less familiar PCP compared to their own PCP, reinforcing the importance of care continuity.
Appendix
This content is only visible if you are logged in and have the appropriate permissions.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Primary Care Telemedicine and Care Continuity: Implications for Timeliness and Short-term Follow-up Healthcare
Authors
Ilana Graetz, PhD
Jie Huang, PhD
Anjali Gopalan, MD, MS
Emilie Muelly, MD, PhD
Andrea Millman, MA
Mary E. Reed, DrPH
Publication date
17-07-2024
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 13/2024
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-024-08914-4

Keynote series | Spotlight on managing health in obesity

Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.

Prof. Eva L. Feldman
Prof. Jonette Keri
Developed by: Springer Medicine
Watch now
Video

Women’s health knowledge hub

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Read more

Keynote webinar | Spotlight on advances in lupus

  • Live
  • Webinar | 27-05-2025 | 18:00 (CEST)

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Join this session to learn more about novel biomarkers for diagnosis and monitoring and familiarise yourself with current and emerging targeted therapies.

Join us live: Tuesday 27th May, 18:00-19:15 (CEST)

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Developed by: Springer Medicine
Register now
Webinar